GlassScriptPhysician profile
Vibitha Mani
NPI 1558705285
$804.46
in general payments reported to CMS, 2019-2025
18 companies · $119 in 2025
The $119 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.58 · 2022: $258 · 2023: $266 · 2024: $94.18 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.40 | 2019-2024 | Gardasil 9, Vaxelis, M-M-R II |
| Pfizer INC. | $132.56 | 2019-2025 | |
| Glaxosmithkline, LLC. | $105.08 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $71.68 | 2019-2024 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.22 | 2022 | |
| Sanofi Pasteur INC. | $36.21 | 2023 | |
| Sanofi-Aventis U.S. LLC | $35.78 | 2025 | |
| Edwards Lifesciences Corporation | $34.48 | 2023 | |
| Exact Sciences Corporation | $32.88 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $32.16 | 2022-2023 | Jardiance, Baqsimi, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $30.55 | 2022 | |
| Sobi, INC | $25.87 | 2023 | |
| Novo Nordisk INC | $20.02 | 2022 | |
| Gilead Sciences, INC. | $17.08 | 2019 | |
| Rare Disease Therapeutics, INC. | $14.86 | 2025 | Xromi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.37 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $12.40 | 2022 | |
| Astellas Pharma US INC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vibitha Mani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.